Revaccination following CAR-T therapy: a needs assessment

Background: CD19-targeted chimeric antigen receptor T-cell (CAR-T) therapy has transformed treatment for relapsed/refractory large B-cell lymphoma, offering promising remission rates. However, it carries significant infectious risks, necessitating revaccination for infection prevention.Methods: This...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Robert Clayden, Barbara Gunka, Brittany Salter, Audrey Y. H. Dong, Kylie Lepic, Gwynivere Davies, Amaris Balitsky
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Taylor & Francis Group 2025-12-01
Цуврал:	Hematology
Нөхцлүүд:	CAR-T vaccination LBCL lymphoma
Онлайн хандалт:	https://www.tandfonline.com/doi/10.1080/16078454.2025.2519865
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!